Cruz A K, Titus R, Beverley S M
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1599-603. doi: 10.1073/pnas.90.4.1599.
We attempted to generate homozygous dhfr-ts (dihydrofolate reductase-thymidylate synthase) knockouts in virulent Leishmania major, an asexual diploid protozoan parasite. Transfection of a neo (neomycin phosphotransferase) targeting fragment yielded heterozygous replacement lines with high efficiency. However, second transfections with a hyg (hygromycin B phosphotransferase) targeting fragment in the presence of metabolites shown to rescue homozygous knockouts in attenuated Leishmania did not yield the expected dhfr-ts- thymidine auxotrophs obtained previously with attenuated lines. Molecular karyotype, Southern blot, and flow cytometric DNA content analysis of clonal transfectants revealed three classes: (i) genomic tetraploids, containing two wild-type dhfr-ts chromosomes and one neo and one hyg replacement chromosome; (ii) aneuploid trisomic lines with one wild-type dhfr-ts and one neo and one hyg replacement chromosome; (iii) diploids bearing homologous integration of the targeting fragment without replacement. Aneuploid and tetraploid lines predominated. This confirms the common impression that natural populations of Leishmania are often aneuploid. The remarkable ability of these parasites to undergo and tolerate changes in chromosome number suggests a general method for testing whether genes are essential for growth in vitro, as the ability of Leishmania to simultaneously undergo homologous gene replacement while retaining wild-type genes by increasing chromosome number provides a diagnostic and positive experimental result. Our results show that virulent Leishmania require at least one copy of dhfr-ts and argue that DHFR-TS plays an unanticipated role in addition to its role in the de novo synthesis of thymidine. These results also have implications for genetic tests of the organization of Leishmania populations.
我们试图在毒性利什曼原虫(一种无性二倍体原生动物寄生虫)中生成纯合二氢叶酸还原酶-胸苷酸合成酶(dhfr-ts)敲除品系。用新霉素磷酸转移酶(neo)靶向片段转染,高效产生了杂合替代品系。然而,在存在已证明可挽救减毒利什曼原虫中纯合敲除品系的代谢物的情况下,用潮霉素B磷酸转移酶(hyg)靶向片段进行第二次转染,并未产生先前在减毒株系中获得的预期dhfr-ts胸苷营养缺陷型。对克隆转染体进行分子核型分析、Southern印迹分析和流式细胞术DNA含量分析,揭示出三类:(i)基因组四倍体,含有两条野生型dhfr-ts染色体以及一条neo和一条hyg替代染色体;(ii)非整倍体三体品系,具有一条野生型dhfr-ts以及一条neo和一条hyg替代染色体;(iii)携带靶向片段同源整合但未发生替代的二倍体。非整倍体和四倍体品系占主导。这证实了利什曼原虫自然群体通常为非整倍体这一普遍印象。这些寄生虫经历并耐受染色体数目变化的显著能力提示了一种测试基因在体外生长是否必需的通用方法,因为利什曼原虫在增加染色体数目的同时能够进行同源基因替代并保留野生型基因,这提供了一个诊断性且积极的实验结果。我们的结果表明,毒性利什曼原虫至少需要一份dhfr-ts拷贝,并表明DHFR-TS除了在胸苷的从头合成中发挥作用外,还发挥着意想不到的作用。这些结果对利什曼原虫群体组织的遗传学测试也有影响。